Neogen Corporation is a diagnostics & research business based in the US. Neogen Corporation shares (NEOG) are listed on the NASDAQ and all prices are listed in US Dollars. Neogen Corporation employs 2,917 staff and has a trailing 12-month revenue of around $924.2 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $16.10 |
|---|---|
| 52-week range | $11.46 - $22.36 |
| 50-day moving average | $16.45 |
| 200-day moving average | $16.02 |
| Wall St. target price | $20.25 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.04 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $16.1 from 2024-09-03
| 1 week (2024-08-29) | -5.96% |
|---|---|
| 1 month (2024-08-05) | -0.31% |
| 3 months (2024-06-05) | 0.56% |
| 6 months (2024-03-05) | -3.94% |
| 1 year (2023-09-05) | -26.82% |
|---|---|
| 2 years (2022-09-01) | -15.26% |
| 3 years (2021-09-03) | 44.53 |
| 5 years (2019-09-05) | 36.03 |
Valuing Neogen Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Neogen Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Neogen Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.6575. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Neogen Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Neogen Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $191.5 million.
The EBITDA is a measure of a Neogen Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $924.2 million |
|---|---|
| Operating margin TTM | 12.3% |
| Gross profit TTM | $409.2 million |
| Return on assets TTM | 1.03% |
| Return on equity TTM | -0.3% |
| Profit margin | -1.02% |
| Book value | $14.52 |
| Market Capitalization | $3.7 billion |
TTM: trailing 12 months
We're not expecting Neogen Corporation to pay a dividend over the next 12 months.
Neogen Corporation's shares were split on a 2:1 basis on 6 June 2021. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Neogen Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Neogen Corporation shares which in turn could have impacted Neogen Corporation's share price.
Over the last 12 months, Neogen Corporation's shares have ranged in value from as little as $11.46 up to $22.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neogen Corporation's is 1.205. This would suggest that Neogen Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies.
Use this calculator to quickly see potential outcomes of your options trades.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.